News Room

OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 23 AUGUST 2010
23rd August 2010
The Share Allotment Committee of the Board in its meeting held on 23 August 2010 has allotted 15,00,000 (fifteen lacs) warrants, carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- at premium of Rs. 68 per share for every warrant held, within 18 months from the date of allotment of the warrants, to the G Consultants and Fabricators Limited, Non promoter, on preferential basis in accordance with the applicable laws

OUTCOME OF THE ANNUAL GENERAL MEETING HELD ON 14 AUGUST 2010
14th August 2010
The members of the Company in its Annual General Meeting held on 14 August 2010 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions with or without modifications unanimously: 1. Adoption of the audited Balance Sheet as at 31 March 2010 and Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon. 2. Appointment of Sh Chandra Mohan as director of the Company, who retires by rotation and being eligible offered himself for re-appointment. 3. Appointment of Mrs Dimple Gupta as director of the Company, who retires by rotation and being eligible offered herself for re-appointment. 4. Re-appointment of M/s S C Vasudeva & Co., Chartered Accountants, New Delhi as Statutory Auditors of the Company 5. Issue of 15,00,000 (Fifteen lac) warrants, carrying the option to the holders of such warrants to subscribe to one equity share of face value of Rs. 10/- at premium of Rs.68/- per share for every warrant held, within a period of 18 months from the date of allotment of the warrants, to G Consultants and Fabricators Limited, Non-Promoter Company, on preferential basis in accordance with the applicable laws.

OUTCOME OF THE BOARD MEETING HELD ON 11 AUGUST 2010
11th August 2010
1. The Board has approved the appointment of Dr Kanwal P Pandita, as Additional Director w.e.f 16 August 2010. 2. The Board has approved un-audited financial results for the quarter ended 30 June 2010 and noted Net Sales for the quarter ended 30 June 2010 is `91.19 crore against `88.05 crore during corresponding quarter ended 30 June 2009. The Profit before interest & depreciation has increased by 89.74% to `16.09 crore during the quarter under review against `8.48 crore during the corresponding quarter ended 30 June 2009.The Company earned cash accrual of `7.48 crore during the quarter under review against `4.45 crore during the corresponding quarter ended 30 June 2009. Profit after Tax earned `1.00 crore during the quarter ended 30 June 2010.

OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON 19 JUNE 2010
19th June 2010
The members of the Company in its Extra-ordinary General Meeting held on 19 June 2010 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the Increase in the Authorised Share Capital of the Company from Rs 35 crore divided into 3 crore equity shares of Rs 10/- each and 50 lacs preference shares of 10/- each to Rs 45 crore divided into 4 crore equity shares of Rs 10/- each and 50 lacs preference shares of 10/- each & consequent amendment in the Memorandum and Articles of Association of the Company by way of passing the ordinary/special resolutions unanimously:

OUTCOME OF THE BOARD MEETING HELD ON 29 MAY 2010
29th May 2010
1. The Board of Directors in its meeting held on 29 May 2010 has approved the Annual accounts for the year ended 31 March 2010 subject to the adoption by the members in its Annual General Meeting. 2. The Board has approved CAPAX of Rs. 130 crore for capacity enhancement and diversification for more pharmaceuticals product.

OUTCOME OF THE ALLOTMENT COMMITTEE MEETING HELD ON 28 MAY 2010
28th May 2010
The Allotment Committee of the Board in its meeting held on 28 May, 2010 has decided to close the FCCB issue on 28 May, 2010 being the closing date, as the FCCB issue of US$5 million have been fully subscribed.

OUTCOME OF THE ALLOTMENT COMMITTEE MEETING 17.05.2010
17th May 2010
Allotment Committee of the Board in its meeting held on 17 May, 2010 has approved and fixed the Wednesday, 19 May, 2010 as the date of opening of issue of US$5 million, Zero Coupon Unsecured Foreign Currency Convertible Bonds (subject to an Option to issue an additional US$10 million of such bonds) in the International Market.

OUTCOME OF THE BOARD MEETING 15.05.2010
15th May 2010
Board of Directors in its meeting held on 15.05.2010 has approved the following matters: 1. Issue of US$5 million, Zero Coupon Unsecured Foreign Currency Convertible Bonds (subject to an Option to issue an additional US$10 million of such bonds) in the International Market and authorized the Committee of the Board to do all acts including to fix the date of opening and closing of the issue of abovesaid securities. 2. Increase in the authorized share capital of the Company from Rs. 35 crore to Rs. 45 crore, subject to the approval of shareholders.

INTERVIEW OF MR RAKESH MAHAJAN IN CNBC-TV 18
15th February 2010
Click to View Video

OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON 09.01.2010
9th January 2010
The members of the Company in its Extra-ordinary General Meeting held on January 9, 2010 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions unanimously: 1. Increase in the Authorised Share Capital of the Company from Rs 30 crores to Rs 35 crores & consequent amendment in the Memorandum and Articles of Association of the Company 2. Issue of 15,00,000 (Fifteen lac) equity shares of face value of Rs.10/- each at a premium of Rs.46/- per share aggregating to Rs 8,40,00,000 (Rupees eight crore forty lac only) to NM Merchantiles Limited, Promoters/ Promoters Companies. 3. Issue of 30,00,000 (Thirty lac) warrants, carrying the option to the holders of such warrants to subscribe to one equity share of face value of Rs. 10/- at premium of Rs.46/- per share for every warrant held, within a period of 18 months from the date of allotment of the warrants, to the following Promoters/ Promoters Companies, on preferential basis in accordance with the applicable laws. a) 10,00,000 (ten lac) warrants to NM Merchantiles Limited b) 10,00,000 (ten lac) warrants to NCG Enterprises Limited c) 10,00,000 (ten lac) warrants to IOL Lifesciences Limited.”

OUTCOME OF THE BOARD MEETING HELD ON 10.12.2009
10th December 2009
The Board of Directors in its meeting held on 10.12.2009 has approved the following matters: 1. Increase in the Authorised Share Capital of the Company from Rs 30 crores to Rs 35 crores. 2. Issue of 15,00,000 equity shares and 30,00,000 equity warrants, carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- for every warrant held, within 18 months from the date of allotment of the warrants at the price to be fixed as per SEBI Regulations to the Promoters / Promoter group companies on the Preferential basis. 3. Convening of Extra-ordinary General Meeting on 09.01.2010. 4. Commencement of trial production of Iso-butyl Benzene, which is basic raw material for Ibuprofen.

CONVENING OF EXTRA-ORDINARY GENERAL MEETING ON 09TH JANUARY, 2010
10th December 2009
The Extra-ordinary General Meeting of the Members of the Company will be held on Saturday, the 09th day of January, 2010 at 10.00 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which has been posted to the Members separately at their registered addresses in India.

OUTCOME OF THE BOARD MEETING HELD ON 31.10.2009
31st October 2009
The Board of Directors in its meeting held on 31.10.2009 approved the Un–audited financial results for the quarter/ half year ended September 30, 2009

CONVENING OF ANNUAL GENERAL MEETING ON 12TH SEPTEMBER, 2009
18th August 2009
The Twenty-second Annual General Meeting of the Members of the Company will be held on Saturday, the 12th day of September, 2009 at 10.00 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which has been posted to the Members separately at their registered addresses in India. Further. the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 8th day of September, 2009 to Saturday, the 12th day of September, 2009 (both days inclusive).

OUTCOME OF THE BOARD MEETING HELD ON 30.06.2009
30th June 2009
The Board of Directors in its meeting held on 30th June, 2009 approved the Annual accounts for the year ended 31st March, 2009 subject to the adoption by the members in its Annual General Meeting . The annual net sales and other income of the Company has decreased by 5% to Rs 30519.36 lacs from Rs 31900.38 lacs. The Profit before interest & depreciation has slightly declined by 2% to Rs 3601.88 lacs during the year under review against Rs 3675.40 lacs during the previous year. However, the net profit after tax has increased by 3% from Rs 1236.33 lacs to Rs 1269.43 lacs during the year under review.

COMPANY HAS COMMENCED THE MANUFACTURING OPERATIONS
28th May 2009
Company has commenced the manufacturing operations of Mono-chloro Acetic Acid (MCA) with the capacity of 7200 TPA, Acetyl Chloride with the capacity of 5200 TPA during the month of May, 2009 as partial completion of its ongoing Expansion cum Backward and Forward Integration project. These products are being used as raw materials for the manufacture of its API Ibuprofen as Backward Integration for its pharma division and as Forward Integration for its chemical division as these two products are being produced by using existing chemicals i.e. Acetic Anhydride and Acetic Acid.

IOL CHEMICALS & PHARMACEUTICALS ALL SET TO EMERGE AS INDIAS LARGEST IBUPROFEN MANUFACTURER
28th May 2009
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has commenced the manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, making it the second largest producer of these chemicals in the country. Both of these chemicals will be used by the company as raw materials for its most popular pharmaceutical product, Ibuprofen. This development has made IOLCP the only Ibuprofen manufacturer in India to have its own captive raw material production unit. Additionally, the enhanced production capacity of Ibuprofen from 3600 TPA to 6000 TPA will make IOLCP the largest producer of the bulk drug (Ibuprofen) in India by the end of this year. IOLCP is also installing another captive co-generation plant of 4 MW, which will take its cogeneration capacity to 17MW to meet the increased energy demand of its production units. The whole project is expected to be completed by the end of December, 2009.

IOLCP GETS STAR EXPORT HOUSE STATUS FROM MINISTRY OF COMMERCE AND INDUSTRY
12th May 2009
Company has been accorded the coveted status of Star Export House in accordance with the provisions of the Foreign Trade Policy, 2004-2009 by the Ministry of Commerce and Industry, Department of Commerce, Government of India, which makes the company eligible for many privileges that will help enhance its business and exports revenues.

PUNJAB STATE SAFETY AWARD 2008 (FIRST PRIZE IN CHEMICAL SECTOR)
5th May 2009
Company has received Punjab State Safety Award 2008 (First Prize in Chemical Sector) for Largest Reduction in Frequency Rate of Accident in Chemical Industry, for more than five lac man hours group

FY 09 RESULTS BY JUN 30, 2009
27th April 2009
Company will publish its Audited Financial Results for the quarter / financial year ended March 31, 2009 within three months from the end of the financial year i.e. on or before June 30, 2009

OUTCOME OF ALLOTMENT COMMITTEE MEETING 21.04.2009
21st April 2009
Allotment Committee of the Board of Directors in its meeting held on April 21, 2009, has allotted 30,66,664 equity shares of Rs 10/- each consisting 12,00,000 equity shares allotted to M/s. Mayadevi Polycot Ltd, Promoter on the conversion of warrants and 18,66,664 equity shares allotted to M/s. indiaSTAR (Mauritius) Ltd, M/s. G S Auto Leasing Ltd and M/s. Shivalik Securities Ltd, Non-promoters on the conversion of fully convertible debentures. Consequent upon the issue of the above 30,66,664 equity shares, the total paid-up capital of the Company stands increased to 2,12,16,664 fully paid equity shares of Rs 10 each.

CREDIT RATINGS
9th April 2009
Credit Analysis and Research Ltd (CARE) with reference to the exiting bank facilities of the Company has retained a "CARE BBB" (triple B) rating to the long term bank facilities aggregating to Rs 225.8 crores of the Company including enhanced facilities of Rs 10 crores. Facilities with this rating are considered to offer moderate safety for timely servicing of debt obligation. Further CARE has retained a "PR2" ( PR two ) rating to the short term bank facilities aggregating to Rs 55 crore of the Company including enhanced facilities of Rs 25 crores. Facilities with this rating would have adequate capacity for timely payment of short term debt obligation.

CHANGE IN DIRECTORATE
4th March 2009
IDBI Bank Ltd vide its letter dated February 16, 2009 has appointed Sh. Parminder Singh Cheema on the Board of the Company as its Nominee Director in place of Smt. Lalita Kapur with effect from March 02, 2009.

OUTCOME OF ALLOTMENT COMMITTEE MEETING 20.02.2009
20th February 2009
Allotment Committee of the Board of Directors in its meeting held on February 20, 2009, has allotted 4,54,000 equity shares of Rs 10/- each to the following persons for cash at a premium of Rs 32/- per share on the conversion of warrants issued on August 21, 2007

COVETED CERTIFICATIONS FOR EXPORTS OF ITS PHARMA PRODUCT, IBUPROFEN
12th February 2009
Company has received coveted certifications for exports of its pharma product, Ibuprofen, to various countries.

NATIONAL ENERGY CONSERVATION AWARD 2008
15th December 2008
IOL Chemicals and Pharmaceuticals Limited (IOLCP), has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. Since 2005, IOLCP has won the National Energy Conservation Award consecutively fourth time. Mr. R K Thukral, Executive Director, IOLCP received this award from Mr. Sushil Kumar Shinde, Hon’ble Minister of Power, Government of India at a special felicitation ceremony held on 14th December, 2008 at New Delhi.

ACCREDITATION CERTIFICATE YOICHI MASUZOE, JAPAN
12th December 2008
The Company has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan

OUTCOME OF THE BOARD MEETING
31st October 2008

The Board of Directors in its meeting held on 31.10.2008 has approved the following

• The Board has also approved the appointment of Sh Yogesh Goel, as Additional Director w.e.f 31.10.2008
• Unaudited financial results for the quarter/half year ended 30th September, 2008 and noted that the Profit after Tax for the quarter ended September 30, 2008, went up by 25.53 % to Rs 4.16 crores from Rs 3.32 crores reported in the corresponding quarter of the previous year. The Operating Profit for the quarter ended September 30, 2008, went up to Rs 8.25 crores against Rs 8.12 crores reported in the corresponding quarter ended September 30, 2007

OUTCOME OF THE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 30.10.2008
30th October 2008
The Allotment Committee of the Board of Directors in its meeting held on 30.10.2008 allotted 24,30,500 equity shares to the Promoter and Non-Promoters.Consequent upon the same, the total paid-up capital of the company stands increased to 1,76,96,000 fully paid equity shares of Rs. 10 each.

OUTCOME OF THE 21ST ANNUAL GENERAL MEETING HELD ON 20.09.2008
20th September 2008

The members of the Company in its Annual General Meeting held on 20th September, 2008 at the Registered office of the Company, Trident Complex, Raikot Road, Barnala, have approved the following matters by way of passing the ordinary/special resolutions with or without modifications unanimously:

• Adoption of the audited Balance Sheet as at 31st March, 2008 and Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon.
• Appointment of Sh. Varinder Gupta as director of the Company, who retires by rotation and being eligible offered himself for re-appointment.
• Appointment of Dr. M A Zahir as director of the Company, who retires by rotation and being eligible offered himself for re-appointment.
• Appointment of Sh Chandra Mohan as director of the Company, who retires by rotation and being eligible offered himself for re-appointment.
• Appointment of Dr. (Mrs) H K Bal as director of the Company, who retires by rotation and being eligible offered herself for re-appointment.
• Appointment of Mrs Dimple Gupta as director of the Company, who retires by rotation and being eligible offered herself for re-appointment.
• Appointment of M/s S C Vasudeva & Co. , Chartered Accountants, New Delhi as Statutory Auditors of the Company in the place of M/s K K Kapoor & Associates, Chartered Accountants, the retiring Auditors of the Company as they have shown their unwillingness to be re-appointed as Statutory Auditors of the Company.
• Appointment of Sh Ravi Pratap Singh as a director of the Company, who was appointed as an additional director on the Board w.e.f. 31.07.2008.
• Appointment of Sh R K Thukral as a director of the Company, who was appointed as additional director on the Board w.e.f 31.07.2008.
• Appointment of Sh R K Thukral as an executive director of the Company for a period of five years w.e.f 31.07.2008.
• Authorisation of the Board of Directors of the Company to borrow moneys not exceeding Rs. 500 crores (Rupees five hundred Crores).
• Authorisation of the Board of Directors of the Company for the creation of charges on the immovable/movable assets of the Company for securing the borrowings not exceeding Rs. 500 crores (Rupees five hundred Crores).
• Approval to the alteration in Articles of Association of the Company.
• Approval to the Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding Rs. 100 crores (Rupees One hundred crores) .
• Approval to the raising of resources through issue of securities in the international market upto US Dollars 25 (twenty five) Millions.
• Approval to the increase in sitting fees of Non Executive directors for attending the Board and Committee meetings to Rs 7,500 and Rs 5,000 respectively.

OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 06.09.2008
6th September 2008
The Allotment Committee of the Board of Directors in its meeting held on 06.09.2008 allotted 18,85,500 equity shares to the promoters and non promoters. Consequent upon the same, the total paid-up equity capital of the company stands increased to 1,52,65,500 fully paid equity shares of Rs. 10 each .

CONVENING OF ANNUAL GENERAL MEETING ON 20TH SEPTEMBER, 2008
27th August 2008
Twenty-first Annual General Meeting of the Members of the Company will be held on Saturday, the 20th day of September, 2008 at 10 A.M at its Registered Office at Trident Complex, Raikot Road, Barnala to transact the business as specified in the Notice which has been posted to the Members separately at their registered addresses. Further, the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, the 16th day of September, 2008 to Saturday, the 20th day of September, 2008 (both days inclusive)

OUTCOME OF THE BOARD MEETING
31st July 2008
The Board of Directors in its meeting held on 31st July, 2008 approved the following matters: 1. The Board has approved the appointment of Sh R K Thukral as Additional Director and Executive Director. He is a Science Graduate having more than 30 years experience in the field of chemical industry. 2. The Board has also approved the appointment of Sh Ravi Pratap Singh, USA citizen, as Additional Director. He is representative of indiaSTAR (Mauritius) Limited, FDI. He has a BS in Mechanical Engineering from University of Delhi and an MBA from Columbia University. 3. The Board considered and approved the Un-audited financial results for the quarter ended 30th June, 2008.

OUTCOME OF THE BOARD MEETING
5th May 2008
The Board of Directors in its meeting held on today that is 5th May, 2008 approved the following matters :
1. Annual accounts for the year ended 31st March, 2008 subject to the adoption by the members in its Annual General Meeting . The Compny has reported turnover of Rs 361.35 crores against Rs 231.87 crores in the previous year recording increase of 56 %. The operating profit of the company has recorded rise of 93 % over that of the previous year from Rs 19.15 crores to Rs 37.02 cores during the year. The company has achieved net profit after tax of Rs 12.36 crores during the current year against Rs 7.55 crores n the previous year showing an increase of 64% .
2. Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding Rs. 50 crores (Rupees Fifty Crores).
3. Raising of sources through issue of securities in the international market upto United State Dollars 10 (ten) Millions.
4. Amendment in articles of association of the company necessitated due to the buy back of shareholding from Punjab State Industrial Development Corporation Limited , state level financial institution by the promoters of the company.

COMBINED CODE OF CORPORATE GOVERNANCE AND CONDUCT
5th May 2008
Due to change in the clause 49 of Listing Agreement and present condition it is require to modify the Combined Code of Corporate Governance and Conduct of the Company. Copy of revised Code of Conduct is available in this web site.

OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON 22.10.2007
22nd October 2007
The members of the Company in its Extra-ordinary General Meeting held on 22.10.2007 approved the issue of:
a) upto 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of Rs. 10/- each at a premium of Rs. 65/- per share aggregating to Rs 9,97,50,000 (Rupees nine crore ninety seven lac fifty thousand only) to M/s. Indiastar (Mauritius) Limited, Non-promoter of the Company.
b) upto 13,99,998 (Thirteen Lac Ninity Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of Rs. 100 each aggregating to Rs. 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of Rs. 10 each at a premium of Rs.65 per share to Indiastar (Mauritius) Limited, Non-promoter of the Company .
c) upto 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- at premium of Rs. 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:
i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company. ii) 11,00,000 (Eleven lacs) warrants to Indiastar (Mauritius) limited, Non-promoter of the Company.”
in accordance with the provisions of Companies Act,1956 SEBI guidelines and the other applicable laws.

OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 22.10.2007
22nd October 2007
The following securities has been allotted to persons mentioned below by the Share Allotment Committee of the Board in its meeting held on 22.10.2007
a) 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of Rs. 10/- each at a premium of Rs. 65/- per share aggregating to Rs 9,97,50,000 (Rupees nine crore ninety seven lac fifty thousand only) to M/s. IndiaSTAR (Mauritius) Limited, Non-promoter of the Company.
b) 13,99,998 (Thirteen Lac Ninety Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of Rs. 100 each aggregating to Rs. 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of Rs. 10 each at a premium of Rs.65 per share to IndiaSTAR (Mauritius) Limited, Non-promoter of the Company .
c) 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- at premium of Rs. 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:
i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company.
ii) 11,00,000 (Eleven lacs) warrants to IndiaSTAR (Mauritius) limited, Non-promoter of the Company.”
in accordance with the provisions of Companies Act,1956 SEBI guidelines and the other applicable laws.
These equity shares/FCDs/warrants will be on the following terms and condition:
Equity shares
1. The equity shares allotted on preferential basis shall be locked-in for a period of one year from the date of their allotment.
FCDs
1. The FCDs will be compulsory converted in one or more trenches within a period of 18 months from the date of allotment into equity shares of face value of Rs 10/- each at a premium of Rs 65/- per share..
2. Interest at the rate of 10% p.a payable monthly until the FCDs are converted into equity shares.
3. The FCDs allotted on preferential basis shall be locked-in for a period of one year from the date of their allotment. The lock in on shares acquired on conversion of FCDs shall be reduced to the extent the FCDs have already been locked-in.
Warrants
1. The warrants shall be attached with an option to subscribe and allotment of one equity share face value of Rs 10/- at a premium of Rs 65/- per share in share capital of the company within 18 months from the date of allotment of the warrants.
2. The warrants issued to M/s Mayadevi Polycot Limited , promoter of the company and to indiaSTAR (Mauritius) Limited ,non promoter of the company be locked in for a period of three years/ one year from the date of allotment respectively and the lock in on equity shares acquired by exercise of the warrants, shall be reduced to the extent the warrants have already been locked-in.
3. The amount deposit against the allotment of warrants will be forefeited in case we failed to exercise the option to subscribe for the allotment of the equity shares within the prescribed period.

OUTCOME OF THE BOARD MEETING HELD ON 15.10.2007
15th October 2007
The Board of Directors in its meeting held on 15.10.2007 considered and approved the un-audited financial results for the quarter/ half year ended 30th September, 2007.

OUTCOME OF THE BOARD MEETING HELD ON 25.09.2007
25th September 2007
The Board of Directors in its meeting held on 25th September , 2007 has reviewed the completion of existing capacities which are as follows :

a. of Acetic acid 50, 000 TPA

b. of Ethyl Acetate 33,000 TPA

c. of Acetic Anhydride 12,000 TPA

d. of Ibuprofen 3600 TPA

and set up of 4MW captive cogeneration plant

and now decided to undertake the expansion of the existing capacities, to set up manufacturing facilities to strengthen back ward and forward integration, cogeneration project with a total project cost of about Rs 180 crores as per the following details to sustain and improve such growth:

Rs in crores

1. Product: Acetic Acid

Existing capacity( TPA): 50,000

Proposed capacity (TPA):60,000



2. Product: Acetic Anhydride

Existing capacity( TPA) : 12,000

Proposed capacity (TPA): 18,000



3 Product: Ibuprofen

Existing capacity( TPA) 3,600

Proposed capacity (TPA) 7,200



4 Product Co generation project

Existing capacity: 4MW

Proposed capacity :14MW



5 Product:Monochloro Acetic Acid and Acetyl chloride

Existing capacity( TPA):-

Proposed capacity (TPA) 6,600 & 4,800



6. Product: Iso Butyl Benzene

Existing capacity( TPA):-

Proposed capacity (TPA) 6,000



The board has also discussed that the company has planned for further expansion of Ibuprofen due to the increasing export demand. Presently the company is exporting its finished products mainly in South Asian countries and the company is taking effective steps for getting USFDA approvals. The company is ideally located nearby to Baddi (H.P.), J & K, & Utrakhand, which are tax exempted zones and various pharmaceuticals companies are coming there for getting the benefits of tax exemption. The company will also be benefited from setting up of backward integration of Ibuprofen with setting up of Captive MCA, Acetyl Chloride and IBB plant. The setting of additional Co-generation plant will make the company self reliance for meeting its own energy requirements. Moreover, the major raw materials are easily available in the vicinity of Punjab & U.P.

The Board decided to complete these expansions by way of partly issuing convertible instruments , term loan from financial institutions and internal accruals .

The Board also approved to issue on preferential basis for cash consideration, in terms of SEBI Guidelines and other applicable laws :

a) upto 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of Rs. 10/- each at a premium of Rs. 65/- per share to M/s. Indiastar (Mauritius) Limited, Non-promoter of the Company, in accordance with the applicable law,

b) up to 13,99,998 (Thirteen Lac Ninity Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of Rs. 100 each aggregating to Rs. 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of Rs. 10 each at a premium of Rs.65 per share to Indiastar (Mauritius) Limited, Non-promoter of the Company .

c) to issue, offer and allot up to 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- at premium of Rs. 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:

i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company.

ii) 11,00,000 (Eleven lacs) warrants to Indiastar (Mauritius) limited, Non-promoter of the Company.”

on such terms and conditions including as to dividend, premium, conversion etc., as the Board may, in its absolute discretion, deem fit .

CONVENING OF EXTRA-ORDINARY GENERAL MEETING ON 22.10.2007
25th September 2007
The Extra-ordinary General Meeting of the Company to be held on Monday, the 22nd day of October, 2007 at 10.00 AM at its registered office situated at Trident Complex, Raikot Road, Barnala for approval of the members to issue on preferential basis for cash consideration, in terms of SEBI Guidelines and other applicable laws :

a) upto 13,30,000 (Thirteen Lac Thirty Thousand) Equity Shares of face value of Rs. 10/- each at a premium of Rs. 65/- per share to M/s. IndiaSTAR (Mauritius) Limited, Non-promoter of the Company, in accordance with the applicable law,

b) up to 13,99,998 (Thirteen Lac Ninity Nine Thousand Nine Hundred Ninety Eight) unsecured 10% fully convertible debentures (FCDs) of Rs. 100 each aggregating to Rs. 13, 99, 99,800 (Rupees Thirteen Crores Ninity Nine Lac Ninety Nine Thousand Eight Hundred only) at an Interest rate of 10% p.a. payable monthly convertible in one and more trenches within a period of 18 months from the date of allotment into equity shares of face value of Rs. 10 each at a premium of Rs.65 per share to IndiaSTAR (Mauritius) Limited, Non-promoter of the Company .

c) to issue, offer and allot up to 23,00,000 (twenty three lacs) warrants ,carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- at premium of Rs. 65/- per share for every warrant held, within 18 months from the date of allotment of the warrants, to following persons, on preferential basis in accordance with the applicable law:

i) 12,00,000 (twelve lacs) warrants to Mayadevi Polycot Limited, Promoter of the Company.

ii) 11,00,000 (Eleven lacs) warrants to IndiaSTAR (Mauritius) limited, Non-promoter of the Company.”

on such terms and conditions including as to dividend, premium, conversion etc., in its absolute discretion as they deem fit .

OUTCOME OF THE ANNUAL GENERAL MEETING HELD ON 22.09.2007
22nd September 2007
The Members in its meeting held on 22.09.2007 has approved the following matters:

1. Considered & adopted the Balance Sheet as at 31.03.2007 and Profit & Loss Account for the year ended on that date alongwith the Auditors, report and Directors’ report. Mr Varinder Gupta , Chairman and Managing Director of the company has acquainted the shareholder with the last years and current years performance . He informed that the company has achieved net sales of Rs 202.73crores during the year ended 31st March, 2007 against Rs 153.16 crores during the year ended 31st March , 2006 recording increase of 32% over the last year . The profit after tax increased from Rs 7.26 crores during the last year to Rs 7.55 crores during the year under review .

2. Appointed Sh. Varinder Gupta as director of the Company Director, liable to retire by rotation

3. Appointed Dr. M A Zahir as director of the Company, liable to retire by rotation

4. Appointed Sh. Yogesh Goel as director of the Company, liable to retire by rotation

5. Appointed Dr. (Mrs) H K Bal as director of the Company, liable to retire by rotation

6. Appointed Sh. Chandra Mohan as director of the Company Director, liable to retire by rotation

7. Appointed Mrs Dimple Gupta as director of the Company, liable to retire by rotation

8. Reappointed M/s K K Kapoor & Associates, Chartered Accountants as Statutory Auditor.

9. Re-appointment of Sh Varinder Gupta as Managing Director of the Company for next five year w.e.f. Ist September, 2007.

CONVENING OF ANNUAL GENERAL MEETING ON 22ND SEPT 2007
28th August 2007
The Annual General Meeting of the Company will be held on Saturday ,the 22nd day of September 2007 at 10 AM at Registered Office of the Company i.e. Trident Complex, Raikot Road, Barnala interalia to consider the following:
1 Adoption of the audited Balance Sheet of the Company as at 31st March 2007 and Profit and Loss Account of the Company for the year ended .on that date alongwith the Reports of the Auditors and the Directors thereon
2 Appointment of Directors in place of Sh. Varinder Gupta, Dr. M A Zahir, Sh. Yogesh Goel, Dr.(Mrs) H K Bal, Sh Chandra Mohan and Mrs Dimple Gupta who retires by rotation being eligible offer themselves for re-appointment..
3 Appointment of M/s K K Kapoor & Associates, Chartered Accountants , the retiring Auditor being eligible offer themselves for re-appointment.
4 Re-appointment of Sh Varinder Gupta as Managing Director for next five year w.e.f 1st September 2007.
Notice of the meeting has been despatched to all members of the Company at their registered address

OUTCOME OF THE SHARE ALLOTMENT COMMITTEE OF THE BOARD HELD ON 21.08.2007
21st August 2007
The Share Allotment Committee of the Board in its meeting held on 21.08.2007 has approved the allotment of 57,00,000 warrants on preferential basis carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- (Rupees ten) at a premium of Rs. 32/- per share for every warrant held, within 18 months from the date of allotment of the warrants,

UPDATES
10th July 2007
The Company has completed the expansion of its Ibuprofen plant and now the installed capacities of Ibuprofen plant stands increased to 3600 TPA per annum from existing 1800 TPA per annum. The plant has been set up as per Regulated Markets parameters i.e USFDA, UKMHRA, etc.

The company has recently expanded the capacities of its Acetic Acid Plant from 30000 TPA to 50000 TPA, Ethyl Acetate Plant from 18000 TPA to 33000 TPA & Acetic Anhydride Plant from 7500 TPA to 12000 TPA. In addition, the company has also set up a 4 MW Co-Generation Plant to meet out its energy requirements.

CONVENING OF EXTRA- ORDINARY GENERAL MEETING ON 23-07-2007
23rd June 2007
The Extra-ordinary General Meeting of the Company will be held on Monday, 23rd day of July, 2007 at 10.00 AM at the Registered Office of the Company i.e. Trident Complex, Raikot Road, Barnala interalia to consider the following:

1.To increase of Authorised Share Capital of the Company from Rs 20 crores to Rs 30 crores .
2. To consider and Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding Rs. 50 crores (Rupees Fifty Crores)
3. To c onsider and issue of securities in the international market upto United State Dollars 10 (ten) Millions.
4. To cosider and issue of 57,00,000 warrants, carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- for every warrant held, within 18 months from the date of allotment of the warrants at the price to be fixed as per SEBI Guidelines to the Promoters and Other Strategic Investors on the Preferential basis.

Notice of the meeting has been despatched to all members of the Company at their registered address.

OUTCOME OF THE BOARD MEETING HELD ON 23.06.2007
23rd June 2007
The Board of Directors in its meeting held on 23.06.2007 has approved the following matters:
1. Allotment of 15,00,000 Equity Shares to M/s Mayadevi Polycot Limited (Promoter) and 11,00,000 Equity Shares to M/s Chamunda Traders Private Limited (Strategic Investor) face value of Rs. 10/- each at the Price of Rs. 42/- per share on Preferential basis.
2. Re-appointment of Sh. Varinder Gupta as Managing Director of the Company
3. Annual Accounts for the Financial Year ended 31st March, 2007.
4. Audited Financial Results for the quarter/year ended 31st March, 2007
5. Issue of Securities to Qualified Institutional Buyers (QIBs) in accordance with the provisions of Chapter XIII A of SEBI (DIP) Guidelines,2000 for an amount not exceeding Rs. 50 crores (Rupees Fifty Crores).
6. Raising of sources through issue of securities in the international market upto United State Dollars 10 (ten) Millions
7. Increase in the Authorised Share Capital of the Company from Rs 20 crores to Rs 30 crores
8. Issue of 57,00,000 warrants, carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- for every warrant held, within 18 months from the date of allotment of the warrants at the price to be fixed as per SEBI Guidelines to the Promoters and Other Strategic Investors on the Preferential basis.
9. Convening of Extra-ordinary General Meeting on 23.07.2007

TRIDENT QUALITY PIONEER AWARD WON BY INDUSTRIAL ORGANICS LTD.
10th February 2007
Industrial Organics Limited has won "Trident Quality Pioneer Award" under the medium-scale business category for Excellence in Quality at the '6th North-West QualTech Convention & Awards 2006' organized by PTU's Gian Jyoti School of TQM & Entrepreneurship, Mohali, on 10th Feb'07. North-West QualTech awards have been instituted for recognizing outstanding Quality Improvement Initiatives of Industry & Business houses in the Northern Region of the country. The awards were presented by Dr. Surinder Kapoor, CMD, Sona Koyo Steering Systems Ltd. and Dr. S.K. Salwan, Vice-Chancellor, Punjab Technical University.

IOL CHEMICALS AND PHARMACEUTICALS LTD. HAS BEEN AWARDED
14th December 2006
IOL Chemicals and Pharmaceuticals Limited has been awarded the ‘National Energy Conservation Award-2006’(2nd Prize) in Chemical Sector by the Ministry of Power, Govt. of India consecutively.

CHANGE OF THE NAME OF THE COMPANY
5th December 2006
The name of the company has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Limited, pursuant to the provisions of section 21 of the Companies Act, 1956, with the approval of Central Government with effect from 05.12.2006.